Inventor
Robert Leanna
Inventor
Grayslake, IL, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations42%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes17%
Y02PClimate change mitigation technologies in the production or processing of goods8%
PatentTitleYear
8,487,116'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20138,034,926'Methods of manufacturing crystalline forms of rapamycin analogs'20118,030,326'Crystalline forms of rapamycin analogs'20117,820,812'Methods of manufacturing crystalline forms of rapamycin analogs'20107,812,032'Crystalline forms of rapamycin analogs'20105,342,981'Substantially isomerically pure hexane or hexene compounds'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2011Patents assigned to ABBOTT LAB (5)· patent assignee history
1994Based in Mundelein, IL, US· patent location history
2010–2013Based in Grayslake, IL, US· patent location history
2013Patents assigned to ABBVIE INC (1)· patent assignee history
2013Patents assigned to BAYBURT EROL K (1)· patent assignee history
2013Patents assigned to CHAMBOURNIER GILLES (1)· patent assignee history
2013Patents assigned to CINK RUSSELL D (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 5 | 1994–2011 |
| ABBVIE INC | 1 | 2013 |
| BAYBURT EROL K | 1 | 2013 |
| CHAMBOURNIER GILLES | 1 | 2013 |
| CINK RUSSELL D | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Grayslake, Illinois, US | 5 | 2010–2013 |
| Mundelein, Illinois, US | 1 | 1994 |